Amneal Pharmaceuticals AMRX Cash Flow Statement (2017-2026)

NASDAQ AMRX
$17.90 -0.21 (-1.16%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-6.04M-20.46M-6.46M-240.08M-2.39M-5.82M-10.13M29.66M25.03M-93.34M-81.68M16.79M11.76M-20.74M24.62M35.61M18.13M49.57M78.00M69.61M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
0.22M0.07M8.06M-4.77M0.19M0.09M7.60M6.56M6.69M5.97M6.72M6.72M7.11M-12.61M21.64M-6.11M6.42M0.32M44.30M0.18M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)
0.30M-0.10M0.20M-0.27M-1.43M2.23M2.46M-6.36M3.12M-13.71M0.10M-1.03M0.93M
Asset Writedowns and Impairment (Quarter)
13.48M15.37M3.58M14.17M11.14M-4.78M41.81M14.83M10.29M22.92M18.57M22.12M-62.69M23.67M22.80M-0.02M13.35M31.60M
Cash from Operations (Quarter)
82.36M63.26M120.34M-125.52M93.57M-23.29M139.71M-11.35M81.39M135.82M-4.41M39.66M141.77M118.08M7.41M83.82M118.45M130.31M-26.74M-21.24M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
2.40M2.33M2.19M2.19M2.10M2.11M2.06M2.46M2.36M4.66M6.80M7.45M8.03M6.82M6.81M6.88M5.03M3.71M3.89M4.06M
Depreciation & Amortization (CF) (Quarter)
Change in Working Capital
Change in Receivables (Quarter)
-24.06M34.52M-124.27M150.83M-60.13M113.29M-195.97M128.99M17.92M-77.23M55.17M100.67M-21.81M28.61M-21.15M53.76M77.61M10.34M-44.01M169.78M
Change in Inventory (Quarter)
11.06M-16.63M25.55M39.85M25.93M11.07M22.51M38.02M42.57M23.09M12.20M23.25M43.10M51.98M13.26M22.78M30.81M20.18M54.96M69.19M
Change in Account Payables (Quarter)
-0.07M1.63M5.13M2.38M-5.03M-0.41M1.67M1.24M1.24M5.67M5.50M4.12M10.72M34.10M-1.12M6.42M-2.19M-2.18M-41.10M-8.53M
Change in Accured Expenses (Quarter)
-11.68M-11.11M-48.78M322.72M-108.51M-55.87M-150.48M42.72M33.08M-19.76M62.17M59.85M46.85M66.26M-112.63M45.62M69.75M18.58M-124.58M66.66M
Other Working Capital Changes (Quarter)
3.50M-5.51M4.42M115.32M-85.37M-44.26M-29.16M-2.74M7.09M-13.00M11.71M-3.29M-6.34M-1.12M0.51M9.50M10.16M-1.01M13.40M10.75M
Investing Activities
Capital Expenditures (Quarter)
10.64M17.50M10.79M5.05M19.10M11.47M9.69M12.00M11.66M9.87M9.20M10.63M16.95M15.15M13.16M22.83M12.30M21.77M8.18M30.70M
Sales of Property, Plant and Equipment (Quarter)
0.52M0.85M
Acquisitions (Quarter)
72.72M
Divestments (Quarter)
7.00M
Cash from Investing Activities (Quarter)
-11.63M-86.97M-97.39M-16.12M-49.33M-11.47M-11.74M-12.28M-13.48M-31.69M-19.76M-6.46M-20.71M-16.06M-17.80M-26.55M-22.46M-45.45M-21.71M-122.74M
Financing Activities
Other financing activities (Quarter)
-0.68M0.85M0.11M0.13M0.42M0.41M0.04M0.03M-0.03M1.00M0.15M0.07M1.68M73.23M-73.01M1.98M
Cash from Financing Activities (Quarter)
-43.55M-30.35M-61.57M23.25M-46.13M-22.17M-12.90M-12.26M-86.58M-100.83M-23.16M-35.09M-92.35M-61.20M-39.17M-41.69M59.44M-10.12M-59.05M79.36M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Exchange Rate Effect (Quarter)
0.29M0.18M-1.57M0.03M-0.40M-3.74M0.77M-0.60M-0.30M0.20M-0.17M-0.10M0.01M-0.74M-0.47M-0.31M-0.69M-0.21M-1.02M-0.16M
Change in Cash (Quarter)
27.47M-53.88M-40.19M-118.36M-2.29M-60.66M115.84M-36.49M-18.98M3.50M-47.49M-2.00M28.72M40.08M-50.03M15.28M154.74M74.53M-108.53M-64.79M
Free Cash Flow (Quarter)
71.72M45.76M109.55M-130.57M74.47M-34.76M130.02M-23.35M69.73M125.96M-13.61M29.03M124.83M102.92M-5.75M60.99M106.15M108.54M-34.92M-51.94M
Net Cash Flow (Quarter)
27.18M-54.06M-38.62M-118.39M-1.89M-56.92M115.08M-35.88M-18.67M3.30M-47.33M-1.89M28.72M40.81M-49.56M15.59M155.43M74.74M-107.51M-64.62M